<- Back to digest

BJJ - 2026-11-01 - Journal Article

Outcomes of a long modular uncemented femoral stem for reconstruction in metastatic femoral disease.

Downie S, Kennedy M, Farhan-Alanie OM, Kennedy IW, McKean G, Kelly MP, Young PS

prospective cohortLOE IIn = 205Mean 45 months (range 12–131)

Topics

oncology
PMID: 42966365DOI: 10.1302/0301-620X.108B11.BJJ-2026-0320.R1View on PubMed ->

Key Takeaway

Long uncemented modular femoral stems (Restoration Modular Revision Hip System Plasma) achieved a 2- and 5-year reintervention probability of only 1.0% for femoral implant failure in 205 patients with metastatic femoral disease, with zero revisions for aseptic loosening.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study evaluated whether a long uncemented modular femoral stem spanning the entire femur could provide durable fixation in metastatic bone disease around the hip while avoiding cement-related complications. 205 patients underwent reconstruction (22% for completed pathologic fracture, 78% for impending fracture) with competing-risk analysis used to account for the 68% mortality rate at mean 20 months postoperatively. Femoral implant failure reintervention probability was 1.0% at both 2 and 5 years, with only 3 reinterventions (all periprosthetic fractures) and no revisions for aseptic loosening; overall surgical complication rate was 8%.

Key Limitation

Absence of a concurrent cemented control group prevents any conclusion about relative superiority over standard cemented reconstruction in terms of complications, functional outcomes, or implant survival.

Original Abstract

AIMS

Cemented arthroplasty has previously been recommended for treating metastatic bone disease (MBD) around the hip. However, cementing has disadvantages, including restricted femoral component length, loosening due to disease progression, and bone cement implantation syndrome (BCIS). A long uncemented implant spanning the whole femur could negate these disadvantages; however, there is a paucity of data regarding their use. Our aim was to assess the outcomes of a long uncemented femoral component in MBD.

METHODS

A total of 205 patients with MBD underwent femoral reconstruction using the Restoration Modular Revision Hip System Plasma stem between January 2008 and December 2025. They were identified from the prospectively collected database of a tertiary MBD service. Any patient with symptomatic bone metastases involving the acetabulum or femur, with completed or impending pathological fracture, were included. The primary endpoint was reintervention for femoral implant failure, with exclusion of reintervention for deep infection and/or instability.

RESULTS

Indications for surgery included pathological fracture (46 of 205; 22%) or lesions at risk of fracture (78%; n = 159). The mean follow-up was 45 months (12 to 131). A total of 140 patients (68%) died during the study period (mean 20 months (0.1 to 128) postoperatively). The mean distance from the centre of the femoral head to the most distal femoral metastasis was 126 mm (5 to 369). Using death as a competing risk, two-year probability of reintervention was 0.010 (95% CI 0.000 to 0.025) and probability of death was 0.507 (95% CI 0.436 to 0.577). At five years, probability of reintervention was 0.010 (95% CI 0.000 to 0.025) and the risk of death was 0.703 (95% CI 0.629 to 0.776). Overall complication rate requiring further surgery was 8% (16 out of 205) with three reinterventions for femoral implant failure (all periprosthetic femoral fractures).

CONCLUSION

This implant demonstrates promising short- to mid-term survivorship, with no patient requiring femoral revision for loosening and a comparatively low complication rate. A long uncemented femoral component may be an appropriate option in selected patients presenting with symptomatic bone metastases around the hip.